ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Dec 02, 2019 16:57 JST
S&P Global Ratings raises Huatai Securities & Huatai International Outlook to Positive
HONG KONG, Dec 02, 2019 - (ACN Newswire) - S&P Global Ratings last week (November 29, 2019) released a report revising its outlook on the long-term ratings on Huatai Securities Co. Ltd. (Stock Code: 6886.HK; "The Company") and its core subsidiary, Huatai International Financial Holdings Co. Ltd. (HTIF), to positive from stable, while also affirming the Company's 'BBB' long-term issuer credit ratings on both companies. S&P Global Ratings expects the Company to maintain its leading position in most of its businesses for the next 24 months as the company exhibits sound risk management as well as a strengthening capitalization.
"The outlook revision reflects our view that Huatai Securities' capital raising actions and new investment trading plan could enhance its capitalization sustainably." said the report. This statement rings true, as the Company's internationalization has greatly accelerated since the beginning of this year. In June 2019, the Company issued the first ever global depository receipt (GDR) under the London-Shanghai stock connect program to successfully list on the London Stock Exchange. Through the listing, the Company's net assets increased to RMB 116.82 billion, which further enhanced its foothold, visibility and participation in the global capital market. In July 2019, AssetMark, the turnkey asset management platform (TAMP) acquired by the Company in 2016, was successfully listed on the New York Stock Exchange, further strengthening the Company's capitalization and paving way for new international development.
This revised rating will help promote Huatai Securities' position within the global capital market, further reduce the cost of overseas financing, and create beneficial conditions for cross-border business. S&P Global Ratings also noted that the Company's rating could be further upgraded if the risk-adjusted capital (RAC) ratio could be sustainably above 15%. (As of June 30, 2019, the company's RAC ratio was 17.2%.)
Sectors: Daily Finance, Daily News
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
TANAKA PRECIOUS METAL TECHNOLOGIES Develops AgSn TLP Sheet, a Sheet-type Bonding Material for Power Semiconductors
Jan 23, 2025 11:00 JST
MHI Receives Order for 3 New Series Trainsets (12 Cars) for Seibu Railway's Yamaguchi Line
Jan 22, 2025 17:27 JST
Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company
Jan 22, 2025 17:18 JST
Mitsubishi Power Advances Thailand's Energy Development with Completion of 1,400MW Combined Cycle Hin Kong Power Plant
Jan 21, 2025 16:24 JST
DENSO Exhibits at Bharat Mobility Global Expo 2025, New Delhi
Jan 20, 2025 20:26 JST
Hitachi Acquires a Sales and Maintenance Service Company for Large Motors in the United States
Jan 20, 2025 15:07 JST
Suzuki's First BEV "e VITARA" Adopts eAxle
Jan 20, 2025 13:58 JST
Honda Presents the World Premier of BF300 Large-size Outboard Motor at the Dusseldorf Boat Show 2025
Jan 20, 2025 11:36 JST
TOYOTA GAZOO Racing begins WRC title bid with a legendary challenge
Jan 17, 2025 19:53 JST
Mitsubishi Corporation and JOGMEC Announce Investment in eFuels provider Infinium
Jan 17, 2025 14:35 JST
NEC Listed on the World Index and Asia Pacific Index of Dow Jones Sustainability Indices (DJSI)
Jan 17, 2025 12:47 JST
Mitsubishi Power Reinforces Commitment to Saudi Arabia's Sustainable Energy Future at Saudi Aramco's IKTVA Forum 2025
Jan 16, 2025 16:56 JST
JCB and DOJO Partner to Help Cardmembers Enjoy a More Seamless Payment Experience
Jan 16, 2025 11:00 JST
MHI Delivers 60 Cars for the Nippori-Toneri Liner Model 330
Jan 15, 2025 16:38 JST
JCB and Taiwan Rakuten Card Launch New JCB Panda Card
Jan 15, 2025 15:00 JST
Fujitsu, Resona Bank and Saitama Resona Bank launch new web service to simplify home-buying process
Jan 15, 2025 13:13 JST
FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Jan 15, 2025 10:03 JST
18th Asian Financial Forum wraps up successfully
Jan 14, 2025 20:56 JST
Honda Civic Hybrid Named 2025 North American Car of the Year, Making Civic the Most Honored Model in the History of the Award
Jan 13, 2025 17:07 JST
Galaxy Payroll: Driving Innovation in Human Resources Management
Jan 10, 2025 23:35 JST
More Latest Release >>